324 related articles for article (PubMed ID: 26889704)
1. Pluripotent Stem Cell-Based Therapies in Combination with Substrate for the Treatment of Age-Related Macular Degeneration.
Pennington BO; Clegg DO
J Ocul Pharmacol Ther; 2016 Jun; 32(5):261-71. PubMed ID: 26889704
[TBL] [Abstract][Full Text] [Related]
2. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
[TBL] [Abstract][Full Text] [Related]
3. Stem cell-derived retinal pigment epithelium transplantation for treatment of retinal disease.
Nommiste B; Fynes K; Tovell VE; Ramsden C; da Cruz L; Coffey P
Prog Brain Res; 2017; 231():225-244. PubMed ID: 28554398
[TBL] [Abstract][Full Text] [Related]
4. Advancing a Stem Cell Therapy for Age-Related Macular Degeneration.
O'Neill HC; Limnios IJ; Barnett NL
Curr Stem Cell Res Ther; 2020; 15(2):89-97. PubMed ID: 31854278
[TBL] [Abstract][Full Text] [Related]
5. Langmuir-Schaefer film deposition onto honeycomb porous films for retinal tissue engineering.
Calejo MT; Ilmarinen T; Vuorimaa-Laukkanen E; Talvitie E; Hakola HM; Skottman H; Kellomäki M
Acta Biomater; 2017 May; 54():138-149. PubMed ID: 28223209
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Age-Related Macular Degeneration with Pluripotent Stem Cell-Derived Retinal Pigment Epithelium.
Vitillo L; Tovell VE; Coffey P
Curr Eye Res; 2020 Mar; 45(3):361-371. PubMed ID: 31777296
[TBL] [Abstract][Full Text] [Related]
7. Concise Review: Making Stem Cells Retinal: Methods for Deriving Retinal Pigment Epithelium and Implications for Patients With Ocular Disease.
Leach LL; Clegg DO
Stem Cells; 2015 Aug; 33(8):2363-73. PubMed ID: 25809736
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of pluripotent stem cells into retinal pigmented epithelium.
Croze RH; Clegg DO
Dev Ophthalmol; 2014; 53():81-96. PubMed ID: 24732763
[TBL] [Abstract][Full Text] [Related]
9. Retinal Pigment Epithelium Replacement Therapy for Age-Related Macular Degeneration: Are We There Yet?
Sharma R; Bose D; Maminishkis A; Bharti K
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():553-572. PubMed ID: 31914900
[TBL] [Abstract][Full Text] [Related]
10. Defined culture of human embryonic stem cells and xeno-free derivation of retinal pigmented epithelial cells on a novel, synthetic substrate.
Pennington BO; Clegg DO; Melkoumian ZK; Hikita ST
Stem Cells Transl Med; 2015 Feb; 4(2):165-77. PubMed ID: 25593208
[TBL] [Abstract][Full Text] [Related]
11. Generation of Transplantable Retinal Pigmented Epithelial (RPE) Cells for Treatment of Age-Related Macular Degeneration (AMD).
Surendran H; Rathod RJ; Pal R
Methods Mol Biol; 2019; 2045():283-298. PubMed ID: 29896658
[TBL] [Abstract][Full Text] [Related]
12. Cell-Based Therapies for Age-Related Macular Degeneration.
Khateb S; Jha S; Bharti K; Banin E
Adv Exp Med Biol; 2021; 1256():265-293. PubMed ID: 33848006
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.
Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO
J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096
[TBL] [Abstract][Full Text] [Related]
14. The identification of small molecules that stimulate retinal pigment epithelial cells: potential novel therapeutic options for treating retinopathies.
Artero-Castro A; Popelka S; Jendelova P; Motlik J; Ardan T; Rodriguez Jimenez FJ; Erceg S
Expert Opin Drug Discov; 2019 Feb; 14(2):169-177. PubMed ID: 30616395
[TBL] [Abstract][Full Text] [Related]
15. Stem Cell-Based RPE Therapy for Retinal Diseases: Engineering 3D Tissues Amenable for Regenerative Medicine.
Ben M'Barek K; Habeler W; Monville C
Adv Exp Med Biol; 2018; 1074():625-632. PubMed ID: 29721996
[TBL] [Abstract][Full Text] [Related]
16. Efficient and robust induction of retinal pigment epithelium cells by tankyrase inhibition regardless of the differentiation propensity of human induced pluripotent stem cells.
Ito A; Ye K; Onda M; Morimoto N; Osakada F
Biochem Biophys Res Commun; 2021 May; 552():66-72. PubMed ID: 33743349
[TBL] [Abstract][Full Text] [Related]
17. Pluripotent stem cells: A therapeutic source for age-related macular degeneration.
Parameswaran S; Krishnakumar S
Indian J Ophthalmol; 2017 Mar; 65(3):177-183. PubMed ID: 28440245
[TBL] [Abstract][Full Text] [Related]
18. A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells.
Maruotti J; Wahlin K; Gorrell D; Bhutto I; Lutty G; Zack DJ
Stem Cells Transl Med; 2013 May; 2(5):341-54. PubMed ID: 23585288
[TBL] [Abstract][Full Text] [Related]
19. Stemming retinal regeneration with pluripotent stem cells.
Jin ZB; Gao ML; Deng WL; Wu KC; Sugita S; Mandai M; Takahashi M
Prog Retin Eye Res; 2019 Mar; 69():38-56. PubMed ID: 30419340
[TBL] [Abstract][Full Text] [Related]
20. Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degeneration.
Melville H; Carpiniello M; Hollis K; Staffaroni A; Golestaneh N
J Transl Med; 2013 Mar; 11():53. PubMed ID: 23452406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
